Community Clinical Oncology Program

社区临床肿瘤学计划

• 批准号: 8850938
• 负责人: David L Grinblatt
• 金额: $ 22.13万
• 依托单位: NORTHSHORE UNIVERSITY HEALTHSYSTEM
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8850938
• 关键词: Area; Breast; Cancer Survivorship; Catchment Area; Chest; Chicago; Clinical; Clinical Research; Clinical Trials; Communities; Community Clinical Oncology Program; Controlled Study; County; Development; Health; Health Promotion and Education; Health system; Healthcare; Illinois; Institution; Leadership; Medical; Patients; Population; Positioning Attribute; Prevention; Quality of life; Research; Underrepresented Minority; United States National Institutes of Health; Universities; base; cancer genetics; cancer therapy; clinical practice; experience; neuro-oncology; oncology; oncology program; programs; suburb; tertiary care

DESCRIPTION (provided by applicant): NorthShore University Health System has over 25 years of successful participation as an NCI-designated CCOP. Over these years we have, in addition to accruing patients, held leadership positions in our research bases, directed national cooperative group studies and brought to the cooperative groups our experience and expertise in many areas such as quality-of-life research, cancer survivorship, thoracic and breast oncology, neuro-oncology and cancer genetics. NorthShore University HealthSystem has the only tertiary care oncology program in our area (population >1.2 million) with consistent participation in NCI-approved cancer treatment, prevention and control studies. We are the major supplier of oncologic healthcare in our area, and a major force for health education and promotion. The specific aims of this renewal proposal are: 1. To continue to offer the populations of the North suburbs of Chicago state-of-the-art clinical research trials covering cancer treatment, control, and prevention. 2. To continue to extend our efforts into Lake County, Illinois (population 713,000), not served by any medical institution with consistent participation in NIH-approved clinical trials in oncology. 3. To disseminate within our catchment area state-of-the-art clinical practice in oncology as an outgrowth of our participation in the CCOP programs. 4. To bring to our national research bases expertise and proposals based on the ongoing research programs and clinical strengths of NorthShore University HealthSystem, and reflecting the needs of our community. 5. To expand our cancer treatment, prevention and control efforts to underserved and minority populations. 6. To continue our leadership positions in our established national research bases and to offer leadership in our new research base.

描述（由申请人提供）：北岸大学卫生系统作为NCI指定的CCOP成功参与了25年以上。这些年来，除了累积患者外，我们还在我们的研究基础上担任领导职务，指导国家合作小组研究，并将我们在许多领域的经验和专业知识带给了合作团体，例如生活质量研究，癌症生存，胸腔和乳房肿瘤学，神经障碍学和癌症学和癌症遗传学。 北岸大学健康系统拥有我们地区唯一的第三级护理肿瘤计划（人口> 120万），持续参与NCI批准的癌症治疗，预防和对照研究。我们是我们地区肿瘤保健的主要供应商，也是健康教育和晋升的主要力量。 该更新建议的具体目的是：1。继续提供芝加哥最先进的临床研究试验的北部郊区，涉及癌症治疗，控制和预防。 2。继续将我们的努力扩展到伊利诺伊州的莱克县（人口713,000），没有由任何医疗机构服务，持续参加了NIH批准的肿瘤学临床试验。 3。要在我们的集水区域内传播肿瘤学的最先进的临床实践，这是我们参与CCOP计划的产物。 4.为了基于北岸大学健康系统的持续研究计划和临床优势，将我们的国家研究基础提出了专业知识和建议，并反映了我们社区的需求。 5。将我们的癌症治疗，预防和控制工作扩大到服务不足和少数群体。 6。在我们既定的国家研究基础上继续我们的领导职务，并在我们的新研究基础上提供领导地位。

项目成果

High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.

高剂量氨基噻二唑治疗晚期结直肠癌。

• DOI: 10.1007/bf00873044
• 发表时间: 1994
• 期刊: Investigational new drugs
• 影响因子: 3.4
• 作者: Locker,GY;Kilton,L;Khandekar,JD;Lad,TE;Knop,RH;Albain,K;Blough,R;French,S;Benson3rd,AB
• 通讯作者: Benson3rd,AB